Studies reporting prevalence estimates for chronic widespread pain
| Study | Pain definition | Sample size | Male (n) | Age range (mean) | Prevalence total (n) | Prevalence in males (%) | Prevalence in females (%) |
|---|---|---|---|---|---|---|---|
| Studies excluded from meta-analysis | |||||||
| Croft et al38 | ACR in the past 1/12 for >3/12 | 11 797 | (0) | (55) | – | – | 12.30 |
| Jones et al33 | ACR in the past 1/12 for >3/12 | 10 453 | – | 44–46 (45) | 12.2% | 11.8 | 12.7 |
| Macfarlane et al22 | ACR in the past 1/12 for >3/12 | 12 069 | 49.4% (3918) | 45 | 11.8% | – | – |
| Vandenkerkhof et al23 | ACR in the past 1/12 for >3/12 | 8572* | – | 45 (45) | 12.3% (1056) | 12.0 | 13.0 |
| Gale et al34 | ACR in the past 1/12 for >3/12 | 11 971 | 49.2% (3399) | 45 (45) | 14.4% (993) | 14.1 | 14.7 |
| Studies included in meta-analysis | |||||||
| Macfarlane et al32 | ACR in the past 1/12 for >3/12 | 3004 | 42.8% (835) | 18–65 | 12.9% (252) | 10.5 | 14.7 |
| Croft et al27 | ACR in the past 1/12 for >3/12 | 2034 | 43.0% (572) | 20–85 (Mdn=46) | 11.2† (164) | 9.40 | 15.60 |
| Aggarwal et al39 | ACR for >3/12 | 4200 | 45% (1035) | 18–75 (Mdn=48) | 14.8% (340) | 9.0 | 17.9 |
| Macfarlane et al40 | ACR in the past 1/12 for >3/12 | 3950 | 41.1% (1020) | 25–65 (Mdn=54) | 15.3% (381) | – | – |
| Beasley et al26 | ACR in the past 1/12 for >3/12 | 14 680* | – | – | 16.5% | – | – |
*n=population responded (denominator not stated).
†Age-adjusted/gender-adjusted estimate.
ACR, American College of Rheumatology; Mdn, median; n, number.